Contract notice: Research and experimental Tender - 19866954

Procurement Summary

Country: Turkey

Summary: Contract notice: Research and experimental development services

Deadline: 21 Mar 2018

Posting Date: 18 Jan 2018

Other Information

Notice Type: Tender

TOT Ref.No.: 19866954

Document Ref. No.: 024518-2018

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

CPV Classification

73100000 - Research and experimental development services
32441100 - Telemetry surveillance system
32441300 - Telematics system
48814400 - Clinical information system
48814000 - Medical information systems
48814200 - Patient-administration system
48180000 - Medical software package
33000000 - Medical equipments, pharmaceuticals and personal care products
33100000 - Medical equipments
33190000 - Miscellaneous medical devices and products
33196000 - Medical aids
33195000 - Patient-monitoring system
72212190 - Educational software development services
72212930 - Training and entertainment software development services
72212931 - Training software development services
80420000 - E-learning services
80320000 - Medical education services
72212180 - Medical software development services
80561000 - Health training services
72212211 - Platform interconnectivity software development services

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Object of the contract
Research and experimental development services
Description: Contract notice: Research and experimental development services
Authority Type: Ministry or any other national or federal authority
Contact Nature: Services
Procedure: Open procedure
Document: Contract notice
Regulation: Other
Award criteria: The most economic tender
CPV code: 73100000, 32441100, 32441300, 48814400, 48814000, 48814200, 48180000, 33000000, 33100000, 33190000, 33196000, 33195000, 72212190, 72212930, 72212931, 80420000, 80320000, 72212180, 80561000, 72212211, 73100000, 32441100, 32441300, 48814400, 48814000, 48814200, 48180000, 33000000, 33100000, 33190000, 33196000, 33195000, 72212190, 72212930, 72212931, 80420000, 80320000, 72212180, 80561000, 72212211
CPV Description: Research and experimental development services.
Telemetry surveillance system.
Telematics system.
Clinical information system.
Medical information systems.
Patient-administration system.
Medical software package.
Medical equipments, pharmaceuticals and personal care products.
Medical equipments.
Miscellaneous medical devices and products.
Medical aids.
Patient-monitoring system.
Educational software development services.
Training and entertainment software development services.
Training software development services.
E-learning services.
Medical education services.
Medical software development services.
Health training services.
Platform interconnectivity software development services.
Pre commercial procurement (PCP) to buy R&D (research & development) services to improve the treatment and self-management of diabetes type 2 patients using a Personalised Diabetes Management Solution
This contract notice invites interested operators to submit tenders to a procurement.
Main Site : Testing is expected to take place in Amadora, PT; Murcia, ES, Naples, IT and Istanbul, TR. At least 50 % of the contracted R&D services must be in EU Member States or Horizon 2020 associated countries.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected operator will be awarded a framework agreement that covers three R&D phases. The three phases are: solution design, prototyping, original development, and validation and testing of a limited set of first products or services. After each phase, intermediate evaluations will be carried out to select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
The procurement is expected to start in May 2018 and end in March 2020.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions i.e. beyond the procurers.
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.
Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.
The open procedure was chosen for formal reasons only. This is because it is not possible to publish a contract notice without selecting one of the listed procedures.
Tenders must be submitted in English. Deliverables must be submitted in English. The PCP language is English and the framework agreement and the specific phase contract must be signed in the English version. Communication (relating to either the tender procedure or the implementation of the contract) must be carried out in English. For field testing in phase 3 the ability to speak the local languages (Spanish, Italian, Turkish and Portuguese) will be an advantage.
For further information please read the procurement documents.
Internet address (URL): www.proempower-pcp.eu
Directive: Classical Directive (2014/24/EU)

Documents

 Tender Notice